BACKGROUND: Currently, there are no data on the association between right ventricular (RV) structure and ECG changes specific for idiopathic pulmonary arterial hypertension (IPAH). Therefore, we aimed to assess the accuracy of the recommended ECG criteria for predicting RV hypertrophy (RVH) and dilation in patients with IPAH. METHODS AND RESULTS: Twelve-lead ECG and cardiovascular magnetic resonance imaging (CMR) were performed in 23 consecutive patients with IPAH aged 49.8±16.3 years. ECG criteria were referred to RV mass index and RV end-diastolic volume index as measured by CMR. Only the ECG voltage criteria based on R wave amplitude in lead V1, R wave amplitude in aVR, P wave amplitude in II and ventricular activation time in V1 were useful for differentiating between patients with and without RVH. A ventricular activation time in lead V1 of <0.01 s excluded RVH, whereas R in V1 >6 mm, R:S in V1 >1, R in aVR >4 mm, R:S in V5 to R:S in V1 <0.04 and P in II >2.5 mm confirmed the diagnosis. Only the ventricular activation time in V1 correlated with RV dilation and when >0.045s confirmed its diagnosis. CONCLUSIONS: Only a few of the recommended ECG criteria proved to be useful in the diagnosis of RVH or RV dilation in patients with IPAH. Changes in the cut-off values improved their accuracy.
BACKGROUND: Currently, there are no data on the association between right ventricular (RV) structure and ECG changes specific for idiopathic pulmonary arterial hypertension (IPAH). Therefore, we aimed to assess the accuracy of the recommended ECG criteria for predicting RV hypertrophy (RVH) and dilation in patients with IPAH. METHODS AND RESULTS: Twelve-lead ECG and cardiovascular magnetic resonance imaging (CMR) were performed in 23 consecutive patients with IPAH aged 49.8±16.3 years. ECG criteria were referred to RV mass index and RV end-diastolic volume index as measured by CMR. Only the ECG voltage criteria based on R wave amplitude in lead V1, R wave amplitude in aVR, P wave amplitude in II and ventricular activation time in V1 were useful for differentiating between patients with and without RVH. A ventricular activation time in lead V1 of <0.01 s excluded RVH, whereas R in V1 >6 mm, R:S in V1 >1, R in aVR >4 mm, R:S in V5 to R:S in V1 <0.04 and P in II >2.5 mm confirmed the diagnosis. Only the ventricular activation time in V1 correlated with RV dilation and when >0.045s confirmed its diagnosis. CONCLUSIONS: Only a few of the recommended ECG criteria proved to be useful in the diagnosis of RVH or RV dilation in patients with IPAH. Changes in the cut-off values improved their accuracy.
Authors: Johannes Krämer; Felix Kreuzer; Michael Kaestner; Peter Bride; Fabian von Scheidt; Jannos Siaplaouras; Heiner Latus; Dietmar Schranz; Christian Apitz Journal: Pediatr Cardiol Date: 2018-03-14 Impact factor: 1.655
Authors: Isaac R Whitman; Vickas V Patel; Elsayed Z Soliman; David A Bluemke; Amy Praestgaard; Aditya Jain; David Herrington; Joao A C Lima; Steven M Kawut Journal: J Am Coll Cardiol Date: 2013-09-28 Impact factor: 24.094
Authors: Narasa Madam; Wassim Mosleh; Natdanai Punnanithinont; Andres Carmona-Rubio; Zaid H Said; Umesh C Sharma Journal: Clin Med Insights Circ Respir Pulm Med Date: 2018-02-11
Authors: Marcin Waligóra; Matylda Gliniak; Jan Bylica; Paweł Pasieka; Patrycja Łączak; Piotr Podolec; Grzegorz Kopeć Journal: J Clin Med Date: 2021-05-16 Impact factor: 4.241
Authors: Michał Piłka; Szymon Darocha; Marta Banaszkiewicz; Maria Wieteska-Miłek; Małgorzata Mańczak; Rafał Mańczak; Piotr Kędzierski; Michał Florczyk; Anna Dobosiewicz; Adam Torbicki; Marcin Kurzyna Journal: Ann Noninvasive Electrocardiol Date: 2020-04-26 Impact factor: 1.468